Examiner: VIVLEMORE, TRACY ANN

Tech Center 4100 • Art Units: 1600 1635 1638 1674 4100 4151

This examiner grants 74% of resolved cases

Performance Statistics

73.5%

Allow Rate

+13.5% vs TC avg

726

Total Applications

+8.1%

Interview Lift

1030

Avg Prosecution Days

Based on 717 resolved cases, 2023–2026

1.5%

§101 Eligibility

19.5%

§102 Novelty

58.0%

§103 Obviousness

9.7%

§112 Clarity

App #	Title	Status	Assignee
18301240	TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST	Non-Final OA	ZJU-HANGZHOU GLOBAL SCIENTIFIC AND TECHNOLOGICAL INNOVATION CENTER
18255690	INTERFERING RNAS TARGETING SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS AND USES THEREOF FOR TREATING COVID-19	Non-Final OA	ONENESS BIOTECH CO. LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.